210 related articles for article (PubMed ID: 36997794)
1. Randomized controlled trials in central serous chorioretinopathy: A review.
Singh SR; Goté JT; Chhablani J
Eye (Lond); 2023 Nov; 37(16):3306-3312. PubMed ID: 36997794
[TBL] [Abstract][Full Text] [Related]
2. Interventions for central serous chorioretinopathy: a network meta-analysis.
Salehi M; Wenick AS; Law HA; Evans JR; Gehlbach P
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011841. PubMed ID: 26691378
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.
Willcox A; Culliford L; Ellis L; Rogers CA; Cree A; Chakravarthy U; Ennis S; Behar-Cohen F; Reeves BC; Sivaprasad S; Lotery A
Eye (Lond); 2019 Feb; 33(2):295-303. PubMed ID: 30194380
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials.
Wang SK; Sun P; Tandias RM; Seto BK; Arroyo JG
Ophthalmol Retina; 2019 Feb; 3(2):154-160. PubMed ID: 31014765
[TBL] [Abstract][Full Text] [Related]
5. One-year outcome of cystoid macular degeneration in central serous chorioretinopathy.
Kumar Sahoo N; Lupidi M; Goud A; Gangakhedkar S; Cardillo Piccolino F; Chhablani J
Eur J Ophthalmol; 2022 Jul; 32(4):2347-2354. PubMed ID: 34615406
[TBL] [Abstract][Full Text] [Related]
6. Central Serous Chorioretinopathy: Morphological and Functional Outcome after Subthreshold Thermal Laser Coagulation with a Frequency-Doubled Nd:YAG Continuous-Wave Laser.
Enders C; Lang GE; Mayer B; Werner JU
Ophthalmologica; 2022; 245(1):59-68. PubMed ID: 34517369
[TBL] [Abstract][Full Text] [Related]
7. Current Therapeutic Approaches to Chronic Central Serous Chorioretinopathy.
Gülkaş S; Şahin Ö
Turk J Ophthalmol; 2019 Feb; 49(1):30-39. PubMed ID: 30829023
[TBL] [Abstract][Full Text] [Related]
8. Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography.
Bonini Filho MA; de Carlo TE; Ferrara D; Adhi M; Baumal CR; Witkin AJ; Reichel E; Duker JS; Waheed NK
JAMA Ophthalmol; 2015 Aug; 133(8):899-906. PubMed ID: 25996386
[TBL] [Abstract][Full Text] [Related]
9. Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.
Demirok G; Kocamaz F; Topalak Y; Altay Y; Sengun A
Int Ophthalmol; 2017 Apr; 37(2):409-416. PubMed ID: 27324370
[TBL] [Abstract][Full Text] [Related]
10. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
11. Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.
Wuarin R; Kakkassery V; Consigli A; Roquelaure D; Papanastasiou A; Schutz JS; Thumann G; Chronopoulos A
Optom Vis Sci; 2019 Jul; 96(7):500-506. PubMed ID: 31274738
[TBL] [Abstract][Full Text] [Related]
12. Central Serous Chorioretinopathy - an Overview.
Berger L; Bühler V; Yzer S
Klin Monbl Augenheilkd; 2021 Sep; 238(9):971-979. PubMed ID: 34416788
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
[TBL] [Abstract][Full Text] [Related]
14. An international collaborative evaluation of central serous chorioretinopathy: different therapeutic approaches and review of literature. The European Vitreoretinal Society central serous chorioretinopathy study.
Romano MR; Parolini B; Allegrini D; Michalewska Z; Adelman R; Bonovas S; Bopp S;
Acta Ophthalmol; 2020 Aug; 98(5):e549-e558. PubMed ID: 31808315
[TBL] [Abstract][Full Text] [Related]
15. Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial.
Breukink MB; Downes SM; Querques G; van Dijk EHC; den Hollander AI; Blanco-Garavito R; Keunen JEE; Souied EH; MacLaren RE; Hoyng CB; Fauser S; Boon CJF
Trials; 2015 Sep; 16():419. PubMed ID: 26390920
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography angiography findings in cystoid macular degeneration associated with central serous chorioretinopathy.
Sahoo NK; Mishra SB; Iovino C; Singh SR; Munk MR; Berger L; Peiretti E; Chhablani J
Br J Ophthalmol; 2019 Nov; 103(11):1615-1618. PubMed ID: 30602447
[TBL] [Abstract][Full Text] [Related]
17. Oral medications for central serous chorioretinopathy: a literature review.
Fusi-Rubiano W; Saedon H; Patel V; Yang YC
Eye (Lond); 2020 May; 34(5):809-824. PubMed ID: 31527760
[TBL] [Abstract][Full Text] [Related]
18. Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative Analysis.
Kapoor KG; Wagner AL
Ophthalmic Res; 2016; 56(1):17-22. PubMed ID: 26982318
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Navigated Laser Photocoagulation for Chronic Central Serous Chorioretinopathy: A Retrospective Observational Study.
Zhou F; Yao J; Jiang Q; Yang W
Dis Markers; 2022; 2022():7792291. PubMed ID: 35465265
[No Abstract] [Full Text] [Related]
20. Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
Dhurandhar DS; Singh SR; Sahoo NK; Goud A; Lupidi M; Chhablani J
Br J Ophthalmol; 2020 Jul; 104(7):904-909. PubMed ID: 31563867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
